Entry139.86→Now143.26
Grail FDA approval can drive upside. Open original source
GRAL GRAIL, Inc. Common Stock Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Source
23:41
Sep 30
Sep 30
CNBC
Grail FDA approval can drive upside.
Grail just received FDA approval for its blood test; Cramer had been waiting for that approval and thinks the stock can go higher and is not done moving, calling it very important.
GRAL
GRAIL, Inc. Common Stock
Long
1ST
—
17:03
Sep 28
Sep 28
r/biotech_stocks
First-gen GRAIL test not good enough yet
The author argues GRAIL's first-generation cancer screening test has roughly a 50-50 chance of being correct when it flags cancer, and the required full diagnostic workup carries real financial and health costs. This false-positive burden makes the product 'almost good enough' rather than commercially compelling today, so the author stands by caution on the current generation. The author concedes the technology's potential is obvious and expects it to eventually get there, implying a longer-term watch rather than a near-term buy.
GRAL
GRAIL, Inc. Common Stock
Avoid
—
16:58
Sep 24
Sep 24
r/biotech_stocks
Grail FDA approval could drive further upside
The author claims Grail Inc could receive FDA approval within the next few months for its early-stage cancer detection testing, citing positive test results. The catalyst is the anticipated FDA approval decision, which the author expects could push the stock higher after its already 53% gain. The main risk implied is that approval may not materialize or the stock may have already priced in the move.
GRAL
GRAIL, Inc. Common Stock
Long
HOLD
—
About GRAL Investor Commentary
Across the available history and selected sources, Buzzberg tracks GRAL (GRAIL, Inc. Common Stock) across 9 sources: 5 bullish vs 1 bearish calls from 11 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 16 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish, 1 other directions. Latest voices: Jim Cramer, u/cedrus_libani, u/zyqyxty14.